Literature DB >> 14112444

CUTANEOUS BLOOD FLOW IN VASCULAR HEADACHES OF THE MIGRAINE TYPE.

A H ELKIND, A P FRIEDMAN, J GROSSMAN.   

Abstract

Entities:  

Keywords:  BLOOD FLOW VELOCITY; ERGOT ALKALOIDS; ERGOTAMINE; FACE; METHYSERGIDE; MIGRAINE; NOREPINEPHRINE; RADIOISOTOPE SCANNING; SODIUM ISOTOPES

Mesh:

Substances:

Year:  1964        PMID: 14112444     DOI: 10.1212/wnl.14.1.24

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.

Authors:  D A CURRAN; J W LANCE
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-10       Impact factor: 10.154

Review 2.  The extracranial vascular theory of migraine: an artificial controversy.

Authors:  Elliot Shevel
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

3.  Effects of drugs on the cerebral circulation of the dog in relation to the cerebral oxygen consumption.

Authors:  W P Chin; S Imai; U Nakano; K Takeda; H Tamatsu; T Ushijima
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

4.  Axonal tracing of autonomic nerve fibers to the superficial temporal artery in the rat.

Authors:  R Uddman; L Edvinsson; H Hara
Journal:  Cell Tissue Res       Date:  1989-06       Impact factor: 5.249

5.  Asymmetry of the aura and pain in migraine.

Authors:  R C Peatfield; M J Gawel; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

6.  Vascular Contributions to Migraine: Time to Revisit?

Authors:  Bianca N Mason; Andrew F Russo
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

Review 7.  Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis.

Authors:  Yu Ri Woo; Yu Jin Han; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.